Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 263

Results For "RI"

10301 News Found

AbbVie and Scripps Research plan to develop anti-viral for Covid-19
News | March 15, 2022

AbbVie and Scripps Research plan to develop anti-viral for Covid-19

The initial SARS-CoV-2 research program at Calibr, the drug discovery and development division of Scripps Research, was supported by funding from the Bill & Melinda Gates Foundation


I Peace triples GMP cell manufacturing by expanding CDMO facility
Biotech | March 15, 2022

I Peace triples GMP cell manufacturing by expanding CDMO facility

The facility registration, along with DMF registration and GMP certification provides peace of mind to clients looking to use our iPSCs for clinical and commercial use in the United States, Japan, and other global markets


Ascletis increases ritonavir production capacity to 530 million tablets a year
Biotech | March 14, 2022

Ascletis increases ritonavir production capacity to 530 million tablets a year

Ritonavir oral tablet is a pharmacokinetic booster of multiple oral antiviral drugs targeting viral proteases and a component of the approved oral antiviral drug Paxlovid (Nirmatrelvir 300 mg tablet + ritonavir 100 mg tablet co-administration package)


USFDA approves Zydus’ Colestipol Hydrochloride tablets
Drug Approval | March 14, 2022

USFDA approves Zydus’ Colestipol Hydrochloride tablets

It is only the second generic application approved by the USFDA


SPAG appoints Ritika Jauhari as President- Strategy & New Business
People | March 14, 2022

SPAG appoints Ritika Jauhari as President- Strategy & New Business

Ritika has also extensively worked with clients such as WHO, GAVI Alliance, USAID, Gilead, Novartis, Sanofi Pasteur


Clarivate deals report highlights emerging trends in biopharma deal-making
Biotech | March 14, 2022

Clarivate deals report highlights emerging trends in biopharma deal-making

RNA, cell & gene therapies, artificial intelligence, CRISPR and oncology-related deals dominate the landscape


Illumina and Trivitron collaborate for next-generation sequencing in India
Medical Device | March 14, 2022

Illumina and Trivitron collaborate for next-generation sequencing in India

In numerous neurological and rare disorders, where clinical characteristics can be confusing, NGS-based approaches have demonstrated considerable increases in disease detection rates over other approaches


Moderna dosed the first participant for an experimental HIV trimer mRNA vaccine
News | March 14, 2022

Moderna dosed the first participant for an experimental HIV trimer mRNA vaccine

The open-label, multicenter, randomized Phase 1 trial is designed to evaluate the safety and immunogenicity of experimental HIV trimer mRNA vaccines


Dr Federica Fiorini is the winner of the 2022 Darlene Solomon award
News | March 14, 2022

Dr Federica Fiorini is the winner of the 2022 Darlene Solomon award

The award recognizes and supports promising women scientists


Illumina welcomes Carissa Rollins as Chief Information Officer
People | March 14, 2022

Illumina welcomes Carissa Rollins as Chief Information Officer

Most recently, Rollins was the Chief Information Officer at UnitedHealthcare